Protective Effects of Gallic Acid on the MPTP-Mediated Dopaminergic Neurons Damage in Parkinson's Disease
JIANG De-qi1,2, YANG Xiao-fei1, CHEN Xiao-si1, LUO Yu-zhi1, QIN Yu-wei1, WEI Meng-qiao1, FAN Yan-ping1
1. College of Biology and Pharmacy, Yulin Normal University, Yulin 537000, China; 2. Guangxi Key Laboratory of Agricultural Resources Chemistry and Biotechnology, Yulin 537000, China
Abstract：OBJECTIVE To study the neuroprotective effects of gallic acid in animal models of Parkinson's disease (PD) and its related molecular mechanisms. METHODS Thirty-six mice were randomly divided into control group, 1-methyl-4-phenyl-1, 2, 3, 6-tetrahydropyridine(MPTP) group and gallic acid group. Mice in MPTP group and gallic acid group were given an intraperitoneal injection of 30 mg·kg-1 MPTP daily for 7 d. The mice in control group were given the same amount of normal saline at the same time. The mice in gallic acid group received oral administration of 200 mg·kg-1 gallic acid daily from the first day, gallic acid was administered continuously for 14 d, and mice in MPTP group and control group received the same amount of normal saline. After 7 d of drug administration, the behavioral function was evaluated by rod climbing test and suspension test. The expression of tyrosine hydroxylase(TH) in the substantia nigra and striatum were detected by immunohistochemistry. The number of apoptotic neurons in the substantia nigra were measured by TUNEL assay. SIRT3 mRNA levels were analyzed by qRT-PCR, and protein expression levels were detected by Western blot. RESULTS Compared with the control group, the ability of motor coordination weakened, the TH expression levels decreased in the substantia nigra and striatum, the number of apoptotic neurons in the substantia nigra significantly increased, the SIRT3 mRNA and protein levels in the substantia nigra obviously declined, and the SOD2 protein expression also dramatically reduced in the MPTP group, the differences between the groups were all statistically significant (P<0.05). After treatment with gallic acid, the ability of motor coordination enhanced, the TH expression level elevated, the number of apoptotic neurons markedly reduced, SIRT3 mRNA and protein levels increased, and SOD2 protein expression also up-regulated in the gallic acid group. Compared with the MPTP group, the differences were all statistically significant (P<0.05). CONCLUSION Gallic acid can improve the behavioral dysfunction and inhibit dopaminergic neurons damage in PD mice. The mechanism of action may be related to the up-regulation of SIRT3 gene expression.
ZHU L, GU P Q, SHEN H. Gallic acid improved inflammation via NF-κB pathway in TNBS-induced ulcerative colitis [J]. Int Immunopharmacol, 2019, 67: 129-137.
[2]
DLUDLA P, NKAMBULE B, JACK B, et al. Inflammation and oxidative stress in an obese state and the protective effects of gallic acid [J]. Nutrients, 2019, 11(1): E23.
[3]
YU M, CHEN X, LIU J, et al. Gallic acid disruption of Aβ1-42 aggregation rescues cognitive decline of APP/PS1 double transgenic mouse [J]. Neurobiol Dis, 2019, 124: 67-80.
[4]
CHANDRASEKHAR Y, KUMAR G P, RAMYA E M, et al. Gallic acid protects 6-OHDA induced neurotoxicity by attenuating oxidative stress in human dopaminergic cell line [J]. Neurochem Res, 2018, 43(6): 1150-1160.
[5]
MANSOURI M T, FARBOOD Y, SAMERI M J, et al. Neuroprotective effects of oral gallic acid against oxidative stress induced by 6-hydroxydopamine in rats [J]. Food Chem, 2013, 138(2-3): 1028-1033.
[6]
LIU Y, CARVER J A, CALABRESE A N, et al. Gallic acid interacts with α-synuclein to prevent the structural collapse necessary for its aggregation [J]. Biochim Biophys Acta, 2014, 1844(9): 1481-1485.
[7]
WANG Y M, GE Y L, ZHAO L N, et al. Current progress on the neuroprotective effects of isothiocyanates in the treatment for experimental Parkinson's disease [J]. Chin Pharm J (中国药学杂志), 2018, 53(5): 325-329.
[8]
MAYA S, PRAKASH T, GOLI D. Evaluation of neuroprotective effects of wedelolactone and gallic acid on aluminium-induced neurodegeneration: relevance to sporadic amyotrophic lateral sclerosis [J]. Eur J Pharmacol, 2018, 835: 41-51.
[9]
ZHENG X H, YANG J, YANG Y H. Research progress on pharmacological effects of gallic acid [J]. Chin Hosp Pharm J (中国医院药学杂志), 2017, 37(1): 94-98, 102.
[10]
MAYA S, PRAKASH T, MADHU K. Assessment of neuroprotective effects of gallic acid against glutamate-induced neurotoxicity in primary rat cortex neuronal culture [J]. Neurochem Int, 2018, 121: 50-58.
[11]
KORANI M S, FARBOOD Y, SARKAKI A, et al. Protective effects of gallic acid against chronic cerebral hypoperfusion-induced cognitive deficit and brain oxidative damage in rats [J]. Eur J Pharmacol, 2014, 733: 62-67.
[12]
MANSOURI M T, NAGHIZADEH B, GHORBANZADEH B, et al. Gallic acid prevents memory deficits and oxidative stress induced by intracerebroventricular injection of streptozotocin in rats [J]. Pharmacol Biochem Behav, 2013, 111: 90-96.
[13]
SAMERI M J, SARKAKI A, FARBOOD Y, et al. Motor disorders and impaired electrical power of pallidal EEG improved by gallic acid in animal model of Parkinson's disease [J]. Par J Biol Sci, 2011, 14(24): 1109-1116.
[14]
ZHANG X, CHEN C Y, DONG J L, et al. Lipid-lowering effects of gallic acid on glutamate-induced obese mice [J]. Chin Tradit Pat Med (中成药), 2017, 39(6): 1115-1119.
[15]
JIANG D Q, WANG Y, LI M X, et al. Current situation of effects of sirtuin3 in neurological diseases [J]. Chin J Clin Pharmacol (中国临床药理学杂志), 2019, 35(5): 493-496.
[16]
ZHANG M, DENG Y N, ZHANG J Y, et al. SIRT3 protects rotenone-induced injury in SH-SY5Y cells by promoting autophagy through the LKB1-AMPK-mTOR pathway [J]. Aging Dis, 2018, 9(2): 273-286.
[17]
CHEN C, SUN J, FU H X, et al. Protective effect of gallic acid on mitochondrial oxidative stress injury [J]. J Int Pharm Res (国际药学研究杂志), 2018, 45(2): 353-359.
[18]
MIRSHEKAR M A, SARKAKI A, FARBOOD Y, et al. Neuroprotective effects of gallic acid in a rat model of traumatic brain injury: behavioral, electrophysiological, and molecular studies [J]. Iran J Basic Med Sci, 2018, 21(10): 1056-1063.
[19]
KIM M J, SEONG A R, YOO J Y, et al. Gallic acid, a histone acetyltransferase inhibitor, suppresses β-amyloid neurotoxicity by inhibiting microglial-mediated neuroinflammation [J]. Mol Nutr Food Res, 2011, 55(12): 1798-1808.
2020, Vol. 55 
